Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Cellular Immunology|September 1, 1992
Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptorC R Maliszewski, P J Morrissey, W C Fanslow, et al.
Seminars in Immunology|October 1, 1994
Structural characteristics of CD40 ligand that determine biological functionW C Fanslow, S Srinivasan, R Paxton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Soluble forms of CD40 inhibit biologic responses of human B cellsW C Fanslow, D M Anderson, K H Grabstein, et al.
The Journal of Biological Chemistry|December 29, 1998
Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154)A E Morris, R L Remmele, R Klinke, et al.
Immunity|March 1, 1996
CD40 ligand is required for protective cell-mediated immunity to Leishmania majorK A Campbell, P J Ovendale, M K Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitorsM A Antonysamy, W C Fanslow, F Fu, et al.
The Journal of Experimental Medicine|August 1, 1993
CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40M R Alderson, R J Armitage, T W Tough, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimerasW J Murphy, S Funakoshi, W C Fanslow, et al.
Pageof 7